
Erik Buntinx: Founder and CEO of ANeuroTech
Erik Buntinx, founder and CEO of ANeuroTech, shares his thoughts with BioBoss host John Simboli about leadership in biopharma and how ANeurotech is working to develop effective treatments, with minima...
20 Huhti 202449min

Helen Torley: CEO of Halozyme Therapeutics
Helen Torley, CEO of Halozyme Therapeutics, shares her thoughts with BioBoss host John Simboli about leadership in biopharma and how Halozyme is working to reinvent the patient experience by easing th...
25 Maalis 202439min

James Graham: CEO of Recce Pharmaceuticals
James Graham, CEO of Recce Pharmaceuticals, shares his thoughts with BioBoss host John Simboli about leadership in biopharma and how Recce is working to develop a new class of synthetic anti-infective...
24 Helmi 202421min

Mike Gaffney: CEO of Cellphire Therapeutics
Mike Gaffney, CEO of Cellphire Therapeutics, shares his thoughts with BioBoss host John Simboli about leadership in biopharma and how Cellphire is working to save lives by bringing novel hemostatic pr...
27 Tammi 202439min

David Baram: Founder and CEO of EmendoBio
David Barmam, founder and CEO of Emendio Biotherapeutics, shares his thoughts with BioBoss host John Simboli about leadership in biopharma and how Emendo is working to evolve traditional CRISPR tools ...
16 Joulu 202336min

Welcome to Season 6 of BioBoss
BioBoss podcast host John Simboli reflects on Seasons 1-5 and invites listeners to Season 6 starting in January 2024
15 Joulu 20231min

Anat Binur: Co-Founder and CEO of Ukko
Anat Binur, co-founder and CEO of Ukko, shares her thoughts with BioBoss host John Simboli about leadership in biopharma and how Ukko is working to improve the lives of people who suffer from food all...
7 Marras 202336min

Markku Jalkanen: Founder and CEO of Faron Pharmaceuticals
Markku Jalkanen, founder and CEO of Faron Pharmaceuticals, shares his thoughts with BioBoss host John Simboli about leadership in biopharma and how Faron is working to develop new immunotherapies to a...
6 Loka 202328min



















